u/tuva_kirchner

losing weight slower does not automatically preserve more lean mass

a U-100 syringe reads 100 units to the millilitre, every time

Split one vial between Janoshik and VendorInvestigate. The two numbers were within half a point of each other and I stopped worrying about which lab to trust.

I would not post that as a finding. It is a single result and the template asks you to say so.

Right — the volume you add is the only variable you control here, and the cake does not change it meaningfully.

Careful with the trend claim. Four results over two years is a very sparse series to draw a line through.

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration. Two results inside that band agree; they do not disagree quietly.

Which endpoint — histological response, fibrosis improvement, or fat fraction?

units are a volume on a U-100 syringe, not a dose

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

The arithmetic in full: concentration is mass over volume, so 15mg into 3mL gives 5mg/mL. A U-100 syringe is graduated at 100 units per millilitre, so 0.75mg is 0.75 divided by 5 millilitres, which is 15 units.

Right, and the trial titration was slow for reasons that are visible in the tolerability tables.

Agreed on the error margin. Quoting a DEXA to one decimal implies a precision the method does not have.

Internal appeals are decided by the plan.

Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.

Yes — date of analysis, because a result from two years ago describes a different manufacturing month.

the log is cumulative, that is the whole value of it

fibrosis improvement without worsening steatohepatitis is the phrase to learn

aim the stream at the glass wall, not at the cake

Correction: that gives 100 units, not what you have written. 15mg into 3mL is 5mg/mL and the division follows from there.

Sent a vial in specifically to check a supplier’s claim after a good experience. It matched. Boring result, worth logging.

Split one vial between VendorInvestigate and Medutest. The two numbers were within half a point of each other and I stopped worrying about which lab to trust.

results without method are gossip with decimals

That only works if the fill weight is exactly the label weight, and it usually is not exactly anything.

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use.

ask the pharmacy to check the wholesaler rather than guessing

strength retention is a decent proxy and it is free

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration. Two results inside that band agree; they do not disagree quietly.

ask for the denial reason in writing, always

If the report gives a mass spectrum as well as UV purity, say so. Identity and relative quantity are separate claims and the log tracks both.

Disagree with the tone strategy. Anger has never moved a determination; matching the criterion has.

Show the arithmetic — where did the unit figure come from?

Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.

the log is cumulative, that is the whole value of it

The template is vendor, compound, batch, service, claim, result, and who paid. Every one of those fields exists because a result missing it has been argued about here before.

three lots beats three tests on one lot

split a vial across two services once and you will never argue about ground truth again

Small fix — that is the New Zealand arrangement, and the question is about Australia.

Yes. Written, always, even when they tell you a phone call is sufficient.

Yes, and the dead-space point is worth repeating: it is small, it is real, and it is the same for every draw.